November 2013 Issue of MMM
November 2013 issue
The battle for patient-centricity sounds a lot like the fight for digital
Click the above link to access the complete Digital Edition of the November 2013 issue, with all text, charts and pictures.
Lifecycle ought to dictate sales approach. So why are mature brands still detailing like it's 2005? Undercover research shows this is a big source of ...
Agencies and clients—are you looking for direction in the way you partner? A little candid advice from the other side may help you stay on ...
In MS, a crop of orals has joined the older established therapies, yielding new options—and fierce competition. One thing they can all agree on: there's ...
The industry's bold-faced names and brightest stars got together for an evening of celebration on October 2 at the MM&M Awards.
Industry experts discuss what it means to truly put patients first, where pharma often falls short and what can be done to rectify this. James ...
Ezra Ernst, Chief commercial officer, Treato
As I pull out my crystal ball, I see a day where we WANT to use secondary research first
A device known as "The Glove" will be able to beam an EKG to any doctor anywhere.
Will J&J ever regain its once stellar reputation for ethics and social responsibility?
Although doors are increasingly closing on reps, data from CMI/Compas show a number of contradictions among healthcare practitioners and what they want when it comes ...
Despite attempts to boost the market profile of Belviq, partners Arena and Eisai appear to be facing the same woes as their prescription-obesity treatment peer ...
News on Merck, Pfizer and United Drug Plc
Med Ed Report
Attendance by physicians crept up in 2012, said the trade group HCEA, but overall turnout was flat, likely because exhibitors brought less personnel along to ...
The North American Thrombosis Forum (NATF) launched an educational initiative on risk assessment and anticoagulation for stroke prevention in atrial fibrillation (AF).
Executives from the Massachusetts General Physicians Organization said their incentive program for salaried physicians boosted clinical quality.
News on Oakstone Publishing, ArcheMedx, Conventus, CircleScience and AxoGen
WorldOne and Sermo announced the launch of their second HUB module, a diabetes resource, at the Diabetes Innovation 2013 conference in Washington, DC last month.
The collaboration between Oncology Nurse Advisor and the National Coalition for Oncology Nurse Navigators became official in October.
News on the American Journal of Obstetrics and Gynecology, Elsevier and Science
Cloud-based CRM, which has been adopted by many a biopharma, has capabilities beyond carrying rep data. What are you doing technologically to ensure clients' field ...
How potential alignment between drug companies and physicians, via the EHR, could extend brand reach.
The agency issued final guidance on mobile apps, saying it will focus only on a subset that present the greatest risk to patients if they ...
News from UCB, Haymarket Media Group, Medivo and Remedy Health
The company has partnered with Univision on a dance competition that supports health and weight loss. The segment, called Ritmo Dieta, will run for 13 ...
GSK's unbranded "disease state" campaign for its biologic drug, Benlysta
Johnson & Johnson's recent Tylenol ad push includes a spot that focuses on parents and all they do for their children
The partnership seeks to improve medication adherence through predictive analytics.
The first on-demand way to tap the influencer community in healthcare went live today, and results of a real-world test show it has the potential ...
Could PAG change the FDA inspection paradigm from honest, objective assessments to faster, easier ones?
The Federal Trade Commission has announced a Dec. 4 workshop to "examine the practice of blending advertisements with news, entertainment, and other content in digital ...
FDA's director of drugs, Janet Woodcock, said in September that she will personally direct the agency's latest push to advance pharmaceutical quality.
Remember when it felt good to say you worked in pharma? How to get the people who benefit from our products to recognize and articulate ...
Here are a few suggestions on how to learn more about the people you'll be spending considerable time with
Everyone knows how to create the expected. But to be a great ad, it takes a little bit of the unexpected. These six show how ...
Jon Sawyer, President and COO, closerlook
At Work With
Gary Pattison, Group managing director, Ogilvy CommonHealth Australia
Manufacturer and agency promotion and hires
Why agencies must get out of the strategy business.
Skill Sets (advertising section)
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.